Diagnostic value of SPIO-mediated breath-hold, black-blood, fluid-attenuated, inversion recovery (BH-BB-FLAIR) imaging in patients with hepatocellular carcinomas

Magnetic Resonance in Medical Sciences

Volumn 9, Issue 2, 2010, Pages 49-58

  Matsushima, Masaya ^a,c   Naganawa, Shinji ^a   Ikeda, Mitsuru ^b   Itoh, Shigeki ^b   Ogawa, Hiroshi ^a   Komada, Tomohiro ^a   Ishigaki, Satoko ^a   Kawai, Hisashi ^a   Suzuki, Koujiro ^a   Satake, Hiroko ^a   Iwano, Shingo ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c Yokkaichi Municipal Hospital   (Japan)

Author keywords

Black blood; Diffusion; Liver; Magnetic resonance; Superparamagnetic iron oxide

Indexed keywords

FERRIC ION; FERRIC OXIDE;

AGED; ANALYSIS OF VARIANCE; ANGIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; BREATHING; COMPUTER ASSISTED TOMOGRAPHY; CYST; DIFFUSION WEIGHTED IMAGING; HUMAN; LIVER; LIVER CELL CARCINOMA; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; TIME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOGRAPHY; AREA UNDER CURVE; CARCINOMA, HEPATOCELLULAR; CYSTS; DIFFUSION MAGNETIC RESONANCE IMAGING; FERRIC COMPOUNDS; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RESPIRATION; ROC CURVE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77958136885     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.9.49     Document Type: Article

References (40)

1. Minematsu K, Li L, Fisher M, Sotak CH, Davis MA, Fiandaca MS. Diffusion-weighted magnetic resonance imaging: rapid and quantitative detection of focal brain ischemia. Neurology 1992; 42: 235-240.
2. van Gelderen P, de Vleeschouwer MH, DesPres D, Pekar J, van Zijl PC, Moonen CT.Water diffusion and acute stroke. Magn Reson Med 1994; 31:154-163.
3. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 1998; 170:397-402.
4. Thoeny HC, De Keyzer F, Oyen RH, Peeters RR. Diffusion-weighted MR imaging of kidneys in healthy volunteers and patients with parenchymal diseases: initial experience. Radiology 2005; 235: 911-917.
5. Sato C, Naganawa S, Nakamura T, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coeficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 2005; 21:258-262.
6. Naganawa S, Sato C, Kumada H, Ishigaki T, Miura S, Takizawa O. Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiology 2005; 15:71-78.
7. Ichikawa T, Erturk SM, Motosugi U, et al. Highb- value diffusion-weighted MRI in colorectal cancer. AJR Am J Roentgenol 2006; 187:181-184.
8. Nakai G, Matsuki M, Inada Y, et al. Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusionweighted magnetic resonance imaging. J Comput Assist Tomogr 2008; 32:764-768.
9. Sumi M, Van Cauteren M, Nakamura T. MR microimaging of benign and malignant nodes in the neck. AJR Am J Roentgenol 2006; 186:749-757.
10. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22:275-282.
11. Anderson AW, Xie J, Pizzonia J, Bronen RA, Spencer DD, Gore JC. Effects of cell volume fraction changes on apparent diffusion in human cells. Magn Reson Imaging 2000; 18:689-695.
12. Fujii S, Matsusue E, Kanasaki Y, et al. Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol 2008; 18:18-23.
13. Namimoto T, Yamashita Y, Sumi S, Tang Y, Takahashi M. Focal liver masses: characterization with diffusion-weighted echo-planar MR imaging. Radiology 1997; 204:739-744.
14. Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006; 239:122-130.
15. Nasu K, Kuroki Y, Sekiguchi R, Nawano S. The effect of simultaneous use of respiratory triggering in diffusion-weighted imaging of the liver. Magn Reson Med Sci 2006; 5:129-136.
16. Okada Y, Ohtomo K, Kiryu S, Sasaki Y. Breathhold T2-weighted MRI of hepatic tumors: value of echo planar imaging with diffusion-sensitizing gradient. J Comput Assist Tomogr 1998; 22:364-371.
17. Hussain SM, De Becker J, Hop WC, Dwarkasing S, Wielopolski PA. Can a single-shot black-blood T2-weighted spin-echo echo-planar imaging sequence with sensitivity encoding replace the respiratory-triggered turbo spin-echo sequence for the liver? An optimization and feasibility study. J Magn Reson Imaging 2005; 21:219-229.
18. Zech CJ, Herrmann KA, Dietrich O, Horger W, Reiser MF, Schoenberg SO. Black-blood diffusionweighted EPI acquisition of the liver with parallel imaging: comparison with a standard T2-weighted sequence for detection of focal liver lesions. Invest Radiol 2008; 43:261-266.
19. Naganawa S, Kawai H, Fukatsu H, et al. Diffusionweighted imaging of the liver: technical challenges and prospects for the future. Magn Reson Med Sci 2005; 4:175-186.
20. Takeshita K, Nagashima I, Frui S, et al. Effect of superparamagnetic iron oxide-enhanced MRI of the liver with hepatocellular carcinoma and hyperplastic nodule. J Comput Assist Tomogr 2002; 26: 451-455.
21. Metz CE, Herman BA, Shen JH. Maximum likelihood estimation of receiver operating characteris-tic (ROC) curves from continuously-distributed data. Stat Med 1998; 17:1033-1053.
22. Dorfman DD, Berbaum KS, Metz CE. Receiver operating characteristic rating analysis: generalization to the population of readers and patients with the jackknife method. Invest Radiol 1992; 27:723-731.
23. Roe CA, Metz CE. Dorfman-Berbaum-Metz method for statistical analysis of multireader, multimodality receiver operating characteristic data: validation with computer simulation. Acad Radiol 1997; 4:298-303.
24. Matsui O, Takashima T, Kadoya M, et al. Dynamic computed tomography during arterial portography: the most sensitive examination for small hepatocellular carcinomas. J Comput Assist Tomogr 1985; 9:19-24.
25. Hayashi M, Matsui O, Ueda K, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 1999; 172:969-976.
26. Kawamori Y, Matsui O, Kadoya M, Yoshikawa J, Demachi H, Takashima T. Differentiation of hepatocellular carcinomas from hyperplastic nodules induced in rat liver with ferrite-enhanced MR imaging. Radiology 1992; 183:65-72.
27. Imai Y, Murakami T, Yoshida S, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 2000; 32:205-212.
28. Shinmura R, Matsui O, Kadoya M, et al. Detection of hypervascular malignant foci in borderline lesions of hepatocellular carcinoma: comparison of dynamicmulti-detector row CT, dynamicMRimaging and superparamagnetic iron oxide-enhanced MR imaging. Eur Radiol 2008; 18:1918-1924.
29. Coenegrachts K, Delanote J, Ter Beek L, et al. Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single- shot T2 weighted turbo spin echo techniques. Br J Radiol 2007; 80:524-531.
30. Goshima S, Kanematsu M, Kondo H, et al. Diffusion-weighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatic lesions. J Magn Reson Imaging 2008; 28:691-697.
31. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Human Pathology 1991; 22:172-178.
32. Terada T, Ueda K, Nakanuma Y. Histopathological and morphometric analysis of atypical adenomatous hyperplasia of human cirrhotic livers. Virchows Arch A Pathol Anat Histopathol 1993; 422:381-388.
33. Xu H, Li X, Xie JX, Yang ZH, Wang B. Diffusionweighted magnetic resonance imaging of focal hepatic nodules in an experimental hepatocellular carcinoma rat model. Acad Radiol 2007; 14:279-286.
34. Monzawa S, Omata K, Shimazu N, Yagawa A, Hosoda K, Araki T. Well-differentiated hepatocellular carcinoma: findings of US, CT, andMRimaging. Abdom Imaging 1999; 24:392-397.
35. Nakao N, Kamino K, Miura K, Takayasu Y, Ohnishi M, Miura T. Transcatheter arterial embolization in hepatocellular carcinoma: a long-term follow- up. Radiat Med 1992; 10:13-18.
36. Castells A, Bruix J, Bru C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993; 18:1121-1126.
37. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1,000 cases. Cancer 2005; 103:1201-1209.
38. Montet X, Lazeyras F, Howarth N, et al. Specificity of SPIO particles for characterization of liver hemangiomas using MRI. Abdom Imaging 2004; 29:60-70.
39. Elizondo G, Weissleder R, Stark DD, et al. Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. Radiology 1990; 174:797-801.
40. Kim YK, Kwak HS, Kim CS, Chung GH, Han YM, Lee JM. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Radiology 2006; 238:531-541.